Pharmacokinetic Comparison of Orally Disintegrating and Conventional Donepezil Formulations in Healthy Korean Male Subjects: A Single-Dose, Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study-Reference-Cited by-同舟云学术

Pharmacokinetic Comparison of Orally Disintegrating and Conventional Donepezil Formulations in Healthy Korean Male Subjects: A Single-Dose, Randomized, Open-Label, 2-Sequence, 2-Period Crossover Study

Published:2011-07 Issue:7 Volume:33 Page:965-972
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Kim Kyoung-Ah,Lim Jong Lae,Kim Chin,Park Ji-Young

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference27 articles.

1. Central and peripheral activity of cholinesterase inhibitors as revealed by yawning and fasciculation in rats;Ogura;Eur J Pharmacol,2001

2. Research and development of donepezil hydrochloride, a new type of acetylcholinesterase inhibitor;Sugimoto;Jpn J Pharmacol,2002

3. Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study;Rogers;Arch Intern Med,1998

4. Donepezil for dementia due to Alzheimer's disease;Birks;Cochrane Database Syst Rev,2006

5. Clinical profile of donepezil in the treatment of Alzheimer's disease;Doody;Gerontology,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Donepezil Hydrochloride BCS Class Ambiguity: Relevant Aspects to be Considered in Drug Classification;Journal of Pharmaceutical Sciences;2022-11

2. ABCG2 Single Nucleotide Polymorphism Affects Imatinib Pharmacokinetics in Lower Alpha-1-Acid Glycoprotein Levels in Humans;Frontiers in Pharmacology;2021-04-29

3. Formulation Strategies to Improve Nose-to-Brain Delivery of Donepezil;Pharmaceutics;2019-02-01

4. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017;Pharmacopsychiatry;2017-09-14

5. Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation;Expert Opinion on Drug Safety;2017-07-12